Unilateral Laparoscopic TAP Block vs. Local Infiltration in Post-Cholecystectomy Analgesia

NCT ID: NCT07176299

Last Updated: 2025-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-14

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compared different methods of pain control after laparoscopic gallbladder removal. A total of 160 patients were randomly assigned to receive either a unilateral laparoscopic TAP block, local anesthetic infiltration, a combination of both, or no regional anesthesia. Pain scores, use of pain medication, and complications were measured up to 24 hours after surgery. The TAP block group experienced less pain and fewer wound-related problems, showing that this method is safe and effective for postoperative pain relief.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Gallbladder stones are a common condition, and laparoscopic cholecystectomy is the standard treatment. Effective pain control after surgery is important for recovery and patient comfort. Traditionally, local anesthetic infiltration (LAI) at the surgical wound sites is used. Another method, the transversus abdominis plane (TAP) block, may provide better pain relief.

This prospective, randomized clinical trial was conducted at the University Clinical Hospital in Olsztyn, Poland. A total of 160 patients undergoing elective laparoscopic cholecystectomy were randomized into four groups: TAP block, LAI, TAP+LAI, and control. All patients received the same type of anesthesia and standard pain medications.

The primary goal was to compare pain intensity within 24 hours after surgery using the Numerical Rating Scale (NRS). Secondary measures included use of additional painkillers, recovery scores (Aldrete), and possible complications at the wound site. The influence of surgical drains and gallstone size on pain was also examined.

The study found that the unilateral laparoscopic TAP block provided the best pain relief, fewer wound-related complications, and reduced need for additional medications compared with other methods. These results suggest that the laparoscopic TAP block is a safe and effective option for improving postoperative pain management after gallbladder surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholelithiasis Cholecystectomy, Laparoscopic Pain, Postoperative Anesthesia, Local Nerve Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants were randomly assigned in a 1:1:1:1 ratio to one of four parallel groups:

1. unilateral laparoscopic TAP block,
2. local anesthetic infiltration (LAI),
3. combined TAP+LAI,
4. control (no regional anesthesia).

Each participant remained in the assigned group throughout the study.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Patients were blinded to group allocation. The statistician analyzing the results was also blinded. Care providers performing the procedures were not blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAP Block

Participants received a unilateral laparoscopic transversus abdominis plane (TAP) block performed under direct laparoscopic vision using 20 mL of 0.25% bupivacaine.

Group Type EXPERIMENTAL

Unilateral laparoscopic TAP block (0.25% bupivacaine)

Intervention Type PROCEDURE

Injection of 20 mL 0.25% bupivacaine into the transversus abdominis plane under direct laparoscopic vision.

Local Anesthetic Infiltration (LAI)

Participants received local infiltration of 20 mL of 0.25% bupivacaine at the trocar insertion sites under laparoscopic guidance.

Group Type ACTIVE_COMPARATOR

Local anesthetic infiltration (0.25% bupivacaine)

Intervention Type PROCEDURE

Injection of 20 mL 0.25% bupivacaine distributed across trocar insertion sites under laparoscopic guidance.

TAP + LAI

Participants received a combination of unilateral laparoscopic TAP block (10 mL of 0.25% bupivacaine) and local anesthetic infiltration at trocar sites (10 mL of 0.25% bupivacaine).

Group Type EXPERIMENTAL

Combined TAP block and local anesthetic infiltration (0.25% bupivacaine)

Intervention Type PROCEDURE

10 mL of 0.25% bupivacaine given as a TAP block and 10 mL administered as local infiltration at trocar sites.

Control (No Regional Anesthesia)

Participants did not receive regional anesthesia. Postoperative pain management was provided only with standardized intravenous analgesics.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Unilateral laparoscopic TAP block (0.25% bupivacaine)

Injection of 20 mL 0.25% bupivacaine into the transversus abdominis plane under direct laparoscopic vision.

Intervention Type PROCEDURE

Local anesthetic infiltration (0.25% bupivacaine)

Injection of 20 mL 0.25% bupivacaine distributed across trocar insertion sites under laparoscopic guidance.

Intervention Type PROCEDURE

Combined TAP block and local anesthetic infiltration (0.25% bupivacaine)

10 mL of 0.25% bupivacaine given as a TAP block and 10 mL administered as local infiltration at trocar sites.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 20 to 85 years
* Scheduled for elective laparoscopic cholecystectomy for symptomatic cholelithiasis confirmed by ultrasonography
* American Society of Anesthesiologists (ASA) physical status I-II
* Provided written informed consent

Exclusion Criteria

* ASA physical status III-IV
* Contraindications to laparoscopy
* Acute cholecystitis diagnosed preoperatively or perioperatively
* Chronic analgesic use
* Spinal degenerative joint disease
* Known allergy to local anesthetics
* Opioid or alcohol dependence
* Psychiatric or neurological disorders
* Lack of consent or withdrawal of consent
Minimum Eligible Age

20 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Warmia and Mazury in Olsztyn

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Łukasz Dyśko

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Clinical Hospital in Olsztyn

Olsztyn, Warmian-Masurian Voivodeship, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

University of Warmia and Mazur

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EOIB for Laparoscopic Cholecystectomy
NCT06656299 RECRUITING NA